Direct immunofluorescence study in autoimmune bullous disorders of skin
DOI:
https://doi.org/10.7439/ijbar.v4i9.467Keywords:
Tuberculosis, Drug resistant, Treatment, Recurrent, BangladeshAbstract
Background and objectives: This study was taken up to know the utility of application of Direct Immunofluorescence on skin biopsies with particular reference to Autoimmune Bullous disorders. The objectives of the present study was to detect specific patterns of DIF in different Autoimmune bullous disorders, to supplement clinical and histopathological features, and hence for confirmatory diagnosis of these disorders. Methods: DIF using fluorescent labelled antibodies IgG, IgM, IgA and C3 - was carried out in 60 clinically suspected cases of Autoimmune bullous disorders referred to Department of Pathology, KIMS Hospital and Research Center, Bangalore, over a period of 18 months from January 2011 to July 2012. Results: Out of 60 cases analysed, 39 cases were given a final diagnosis as Autoimmune bullous disorder based on clinical, histopathological and DIF findings. DIF positivity was observed in 34 cases. DIF findings correlated with clinical and histopathological findings in 37 cases (94.8%). Interpretation and Conclusion: In this study we found out that DIF serves as a simple, highly sensitive, cost-effective and hence gold standard test for Autoimmune bullous disorders. The technique is essential to supplement clinical findings and histopathology in the diagnosis of these Immunobullous disorders.Downloads
Download data is not yet available.
Downloads
Published
2013-09-30
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
Direct immunofluorescence study in autoimmune bullous disorders of skin. (2013). International Journal of Biomedical and Advance Research, 4(9), 610-618. https://doi.org/10.7439/ijbar.v4i9.467